Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2015-07-13 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NANGIS (77370), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DE LA HALLE : revenue, balance sheet and financial ratios
SELAS PHARMACIE DE LA HALLE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NANGIS (77370),
this company of category PME
shows in 2023 a net income positive of 367 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DE LA HALLE (SIREN 812253029)
Indicator
2023
2022
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
367 182 €
454 479 €
144 434 €
146 048 €
207 906 €
105 235 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SELAS PHARMACIE DE LA HALLE generates positive net income of 367 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 105 k€ -> 367 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
367 182 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 54%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
54.26%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.838%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DE LA HALLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2022
2023
Debt ratio
353.158
237.72
190.293
156.301
64.26
54.26
Financial autonomy
19.041
25.855
30.507
34.172
53.464
57.838
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
54.262023
2019
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-16 pts over 3 years
In 2023, the debt ratio of SELAS PHARMACIE DE LA HALLE (54.26) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
57.84%2023
2019
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good+21 pts over 3 years
In 2023, the financial autonomy of SELAS PHARMACIE DE LA HALLE (57.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 243.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
243.973
Liquidity indicators evolution SELAS PHARMACIE DE LA HALLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2022
2023
Liquidity ratio
71.603
77.602
72.925
97.336
210.171
243.973
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
243.972023
2019
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good+46 pts over 3 years
In 2023, the liquidity ratio of SELAS PHARMACIE DE LA HALLE (243.97) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELAS PHARMACIE DE LA HALLE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELAS PHARMACIE DE LA HALLE is estimated at
4 332 555 €
(range 2 634 834€ - 6 090 600€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
2634k€4332k€6090k€
4 332 555 €Range: 2 634 834€ - 6 090 600€
NAF 5 année 2023
Valuation method used
Net Income Multiple
367 182 €
×
11.8x
=4 332 555 €
Range: 2 634 834€ - 6 090 600€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DE LA HALLE with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DE LA HALLE
What is the revenue of SELAS PHARMACIE DE LA HALLE ?
The revenue of SELAS PHARMACIE DE LA HALLE is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DE LA HALLE profitable?
Yes, SELAS PHARMACIE DE LA HALLE generated a net profit of 367 k€ in 2023.
Where is the headquarters of SELAS PHARMACIE DE LA HALLE ?
The headquarters of SELAS PHARMACIE DE LA HALLE is located in NANGIS (77370), in the department Seine-et-Marne.
Where to find the tax return of SELAS PHARMACIE DE LA HALLE ?
The tax return of SELAS PHARMACIE DE LA HALLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DE LA HALLE operate?
SELAS PHARMACIE DE LA HALLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart